Page last updated: 2024-08-24

triazoles and Opportunistic Infections

triazoles has been researched along with Opportunistic Infections in 137 studies

Research

Studies (137)

TimeframeStudies, this research(%)All Research%
pre-19903 (2.19)18.7374
1990's5 (3.65)18.2507
2000's61 (44.53)29.6817
2010's63 (45.99)24.3611
2020's5 (3.65)2.80

Authors

AuthorsStudies
Chen, SC; Cornely, OA; Hoenigl, M; Jenks, JD; Thompson, GR1
Badali, H; Dadashzadeh, M; Diba, K; Fakhim, H; Kurzai, O; Mahdi, D; Nasri, E; Vaezi, A; Walther, G1
Adas, M; Bechman, K; Clarke, B; Galloway, J; Yates, M1
Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA; Rhomberg, P1
Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA; Rhomberg, PR1
Bassetti, M; Bouza, E1
Chen, L; Dong, W; Dong, Y; Li, Y; Meng, T; Wang, Y; Xie, J; Xing, Y1
Ahangarkani, F; Aslani, N; Badali, H; Boekhout, T; Hagen, F; Kolecka, A; Meis, JF; Meyabadi, MF; Shokohi, T1
Aghili, SR; Ghasemi, M; Gholinejad Ghadi, N; Haghani, I; Nikkhah, M; Seifi, Z; Shokohi, T; Vahedi Larijani, L1
Ho, CL; Lee, CH; Lin, C; Lin, JC1
Abi-Saab, W; Besuyen, R; Coates, LC; Dudek, A; Gladman, DD; Greer, JM; Harrison, P; Helliwell, PS; Kunder, R; Mease, P; Meuleners, L; Mozaffarian, N; Rychlewska-Hanczewska, A; Stanislavchuk, M; Tasset, C; Van den Bosch, F; Van der Aa, A1
Abi-Saab, W; Baraliakos, X; Besuyen, R; Deodhar, A; Gensler, LS; Greer, JM; Hendrikx, T; Landewé, R; Liu, K; Maksymowych, WP; Meuleners, L; Mozaffarian, N; Nadashkevich, O; Tasset, C; Tseluyko, V; van der Heijde, D1
Ahmed, G; Ahmed, N; El-Mahallawy, H; Hafez, H; Hassanain, O; Khedr, R; Madney, Y; Taha, H; Youssef, A1
Ally, MT; Gupta, V; Jenkins, IH1
Bruneel, F; de Roquetaillade, C; Hamon, M; Paktoris, H1
Cadelis, G1
Chen, H; Hu, J; Hu, L; Jiang, M; Li, B; Li, Y; Lou, X; Ning, H; Wang, J; Xu, C; Yu, Z1
Bulacio, L; Escovich, L; López, C; Pairoba, C; Paz, M; Ramadán, S; Ramos, L; Sortino, M1
Arıkan Akdağlı, S; Aydeniz Ozansoy, F; Dursunoğlu, N; Ergin, C; Kutlu, M; Sarı, I; Sarıbaş, Z1
Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA; Rhomberg, PR2
Bobek-Billewicz, B; Foroncewicz, B; Jarząb, B; Krawczyk, M; Mucha, K; Orłowski, T; Pączek, L; Raczyńska, J; Religioni, J1
Aline-Fardin, A; Buot, G; Dannaoui, E; Degulys, A; Guitard, J; Hennequin, C; Lapusan, S; Marie, JP; Rio, B1
Costantino, F; Di Biasi, C; di Coste, A; Duse, M; Ernesti, I; Melengu, T; Savastano, V; Schiavi, L; Tarani, L1
Bucknor, MD; Gross, AJ; Link, TM1
Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ1
Morris, AM1
Klimova, K; Padilla Suárez, C; Peláez, T; Salcedo Plaza, M1
Berg, T; Brandmaier, P; Jonas, S; Lübbert, C; Mohr, FW; Pfeiffer, D; Rodloff, A; Schmelzle, M; Schubert, S; Wiltberger, G1
Chang, FY; Chang, PY; Chao, TY; Chen, YC; Dai, MS; Ho, CL; Kan, LP; Kao, WY; Lin, HA; Lin, JC; Lin, TY; Wang, CH; Wang, NC; Wu, YY1
Chen, SC; Gilroy, NM; Morrissey, CO; Slavin, MA; Szer, J; Tam, CS; Thursky, KA; van Hal, SJ; Worth, LJ1
Cassumbhoy, M; Chau, MM; Cooper, CM; Kong, DC; Marriott, DJ; Roberts, JA; Trubiano, JA; Urbancic, K; van Hal, SJ; Wilkes, J; Worth, LJ1
Almeida, AG; Lima da Silva, G; Pinto, FJ1
Chang, SC; Ko, BS; Lee, SH; Sun, HY1
Bouchnerova, J; Hadrabova, M; Kocmanova, I; Lengerova, M; Mayer, J; Palackova, M; Pavlovsky, Z; Racil, Z; Ricna, D; Volfova, P; Weinbergerova, B1
Aala, F; Amirizad, K; Aslani, N; Badali, H; Hashemi, SJ; Khodavaisy, S; Nazeri, M; Nouripour-Sisakht, S; Rezaie, S; Sorkherizi, MS1
Chitasombat, MN; Kontoyiannis, DP1
Chung, SJ; Hwang, WY; Tan, AL; Tan, BH; Tan, TT; Thien, SY1
Arendrup, MC; Frandsen, TL; Jensen, TSR; Juhler, M; Nygaard, U; von Buchvald, C1
Ananda-Rajah, MR; Grigg, A; Slavin, MA1
Fille, M; Hausdorfer, J; Hinterberger, G; Lass-Flörl, C; Mayr, A; Perkhofer, S; Speth, C1
Alastruey-Izquierdo, A; Araujo Ribeiro, M; Cuenca-Estrella, M; Gomez-Lopez, A; Rodriguez-Tudela, JL1
González, GM1
Fanci, R1
Alp, S; Arikan, S; Hasçelik, G; Sancak, B1
Karaahmet, T; Korten, V; Odabasi, Z; Tigen, E; Tigen, K1
George, E; Shinohara, MM1
Besterman, JM; Diekema, DJ; Georgopapadakou, N; Martell, LA; Messer, SA; Pfaller, MA1
Bonadona, A; Faure, O; Hamidfar, R; Karkas, A; Mescam, L; Minet, C; Pison, C; Saint-Raymond, C; Salameire, D; Schwebel, C; Tabah, A; Timsit, JF1
Arendrup, MC; Krarup, E; Larsen, CG; Larsen, FG; Pedersen, M; Thybo, S1
Asmuth, DM; Cooper, DA; Goodrich, J; Haubrich, R; Hirschel, B; Mayer, H; Rajicic, N; Valdez, H1
Kumar, P; Matsumoto, C; Pien, E; Rosen, J; Shanmugam, VK; Steen, V; Whelton, S1
Amigues, I; Barker, J; Chung, D; Cohen, N; Jakubowski, A; Papanicolaou, GA; Plescia, C; Seo, SK1
Corradini, N; Dannaoui, E; Gay-Andrieu, F; Hoinard, D; Lortholary, O; Méchinaud, F; Roux, BG1
Furuya, A; Ida, K; Kato, M; Koh, K; Okamoto, T; Takita, J1
Hariga, D; Khaled, S; Trabelsi, S1
Bermudez, C; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A1
Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A1
Curto, CL; Danvin, JB; Dessi, P; Mimouni, O; Thomassin, JM1
Ayub, A; Kenney, CV; McKiernan, FE1
Kuithan, F; Scheer, F; Wiggermann, P1
Chang, FY; Ho, SJ; Lin, JC; Shang, ST; Wang, NC; Yang, YS1
Almira-Suarez, M; Bertrán-Pasarell, J; Colón-Santos, E; González-Ramos, M; Rodríguez-Vega, G; Vélez-Rosario, R1
Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC1
Chugh, TD; Duggal, S; Jain, H; Sharma, A; Tyagi, A1
Bergstresser, P; Chan, J; Dai, W; Dharamsi, JW; Gander, R; Ricotti, C; Soliman, S1
Alivanis, P; Aperis, G1
Miller, CJ; Seykora, JT; Shinohara, MM1
Choi, SM; Kang, MK; Kim, HJ; Kim, SH; Kwon, JC; Lee, DG; Min, WS1
Aronowitz, P; Tan, S1
Patterson, TF; Thompson, GR1
Kontoyiannis, DP1
Andrés, R; Elías, T; Fernandez de Orueta, L; Pintado, V1
Babor, F; Borkhardt, A; Janßen, G; Laws, HJ; Mackenzie, C; Meisel, R; Sabir, H; Schaper, J; Schuster, F; Siepermann, M; Wessalowski, R1
Cleveland, KO; Gelfand, MS; Rao, V1
Girmenia, C; Iori, AP1
Brisou, P; Darles, C; Gaillard, T; Pons, S; Roméo, E1
Brokalaki, EI; Hillen, U; Sommerwerck, U; von Heinegg, EH1
Bennett, D; Endo, J; Kleker, B; Snow, S1
Aldasoro, E; Cortes-Lletget, C; Espinosa, G; Gállego, M; Gascon, J; Muñoz, J; Oliveira, I; Pinazo, MJ; Posada, Ede J1
De Hoog, GS; Hatemi, G; Kantarcioğlu, AS; Mandel, NM; Yücel, A1
Howden, BP; Mijch, AM; Schwarer, AP; Slavin, MA1
Anghilieri, M; Cafro, AM; Carrafiello, G; Cesana, C; D'Avanzo, G; Marbello, L; Morra, E; Nosari, A1
Cook, C; Fernandez, C; Fraser, R; McCully, B; Schmidt, M; Shouldice, E1
Klopfenstein, KJ; Powell, D; Rosselet, R; Termuhlen, A1
Gallamini, A; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Pugno, F; Viscoli, C1
Martin, PL; Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ1
Innes, JR; Moss, PJ; Thaker, HR; Varma, D; Wedgwood, K1
Rubin, ZA; Somani, J1
Friedrich, W; Gahr, M; Hahn, G; Koch, A; Roesler, J; Rösen-Wolff, A1
Afif, C; Bodey, GP; Boktour, MR; Chatzinikolaou, I; Cooksley, C; Hachem, RY; Kantarjian, HM; Kontoyiannis, DP; Perego, C; Raad, II1
Alkan, Y; Burhenne, J; Haefeli, WE; Shalit, I; Stein, J; Yaniv, I1
Boeckh, M; Carter, RA; Corey, L; Kim, HW; Marr, KA1
Viscoli, C1
Chadwick, EG; Guzman-Cottrill, JA; Zheng, X1
Beltramo, D; Levin, T; Samuel, R; Suh, B1
Herbrecht, R; Kessler, R; Kravanja, C; Letscher-Bru, V; Meyer, MH; Waller, J1
Jagirdar, J; Scott, RS; Sutton, DA1
Bonatti, H; Dierich, MP; Freund, M; Gastl, G; Griff, K; Kropshofer, G; Lass-Flörl, C; Mayr, A; Nachbaur, D; Petzer, A1
Colombo, GL; Morlotti, L; Serra, G1
Gøtzsche, PC; Johansen, HK; Jørgensen, KJ1
Delikou, S; Kitra, V; Miyakis, S; Papadakis, V; Papadatos, I; Parcharidou, A; Polychronopoulou, S; Velegraki, A1
Axer-Siegel, R; Bishara, J; Blau, H; Kramer, M; Kramer, MR; Weinberger, D1
Arechavala, A; Bianchi, MH; López Daneri, G; Negroni, R; Robles, AM; Santiso, G1
Cornely, OA; Glöckner, A1
Akiyama, H; Honma, M; Ito, T; Muramatsu, T; Negishi, K; Ohashi, K; Sakai, M; Sakamaki, H; Shitara, M; Suzuki, T; Ueki, T; Yamashita, T1
Honda, M; Ichiyasu, H; Kohrogi, H; Matsumoto, M; Okamoto, S; Okamoto, T; Sato, K; Tsumori, K; Yamamura, A1
Boparai, N; Chandrasekar, P; Durrant, S; Greinix, H; Langston, A; Lipton, JH; Morais de Azevedo, W; Patino, H; Pedicone, L; Reddy, V; Tarantolo, SR; Ullmann, AJ; Vesole, DH1
Angulo-Gonzalez, D; Cornely, OA; Goh, YT; Hardalo, C; Helfgott, D; Holowiecki, J; Maertens, J; Perfect, J; Petrini, M; Stockelberg, D; Suresh, R; Ullmann, AJ; Walsh, TJ; Winston, DJ1
De Pauw, BE; Donnelly, JP1
Bellmann, R; Weiler, S1
van Dissel, JT; van Nieuwkoop, C1
Kontoyiannis, DP; Lewis, RE1
Jarque, I; Sanz, MA1
Guarro, J; Pastor, FJ1
Feldberg, E; Halperin, D; Lahav, J; Warman, M1
Chandrasekar, P; Krishna, G; Martinho, M; Patino, H; Ullmann, AJ1
Bouza, E; Guinea, J; Peláez, T; Recio, S; Torres-Narbona, M1
Denning, DW; Pasqualotto, AC; Shah, M; Wynn, R1
Bourolias, CA; Karatzanis, AD; Kofteridis, DP; Mantadakis, E; Papazoglou, G; Samonis, G; Velegrakis, GA1
Mavinkurve-Groothuis, AM; van Die, LE; van't Hek, LG; Verweij, PE; Warris, A; Zwitserloot, AM1
Anaissie, EJ; Andersson, BS; Bodey, GP; Champlin, RE; Giralt, SA; Kantarjian, HM; Karl, C; Kontoyiannis, DP; O'Brien, S; Vartivarian, S1
Lee, JW; Walsh, TJ1
Milatovic, D; Schwartz, S; Thiel, E1
Espinel-Ingroff, A2
Anaissie, E; Caillot, D; de Marie, S; Graybill, JR; Viviani, MA; Yamaguchi, H1
Chiou, CC; Groll, AH; Walsh, TJ1
Arnadóttir, M; Asmundsson, P; Bödvarsson, M; Hilmarsdóttir, I; Thorsteinsson, SB1
Helwick, C1
Ernst, EJ; Hoffman, HL; Klepser, ME1
Ellepola, AN; Samaranayake, LP2
Dietrich, D1
Keil, TU1
Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF1

Reviews

32 review(s) available for triazoles and Opportunistic Infections

ArticleYear
Breakthrough invasive fungal infections: Who is at risk?
    Mycoses, 2020, Volume: 63, Issue:10

    Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillus; Candida; Central Venous Catheters; Echinocandins; Fluconazole; Fusarium; Genetic Predisposition to Disease; Hematologic Neoplasms; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Mucorales; Mycoses; Neutropenia; Opportunistic Infections; Organ Transplantation; Penicillium; Risk Factors; Triazoles

2020
The safety of JAK-1 inhibitors.
    Rheumatology (Oxford, England), 2021, 05-05, Volume: 60, Issue:Suppl 2

    Topics: Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Diverticular Diseases; Herpes Simplex; Herpes Zoster; Heterocyclic Compounds, 3-Ring; Humans; Immunocompromised Host; Infections; Intestinal Perforation; Janus Kinase 1; Janus Kinase Inhibitors; Latent Infection; Opportunistic Infections; Pyridines; Triazoles

2021
Invasive mould infections in the ICU setting: complexities and solutions.
    The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Critical Illness; Galactose; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Lung Diseases, Fungal; Mannans; Mucor; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory System; Triazoles; Voriconazole

2017
Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:8

    Topics: Antifungal Agents; Aspergillosis; Fever; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Invasive Fungal Infections; Network Meta-Analysis; Neutropenia; Opportunistic Infections; Randomized Controlled Trials as Topic; Triazoles

2018
Rhinocerebral zygomycosis with pansinusitis in a 14-year-old girl with type 1 diabetes: a case report and review of the literature.
    Italian journal of pediatrics, 2013, Dec-10, Volume: 39

    Topics: Adolescent; Antifungal Agents; Blindness; Diabetes Mellitus, Type 1; Disease Progression; Electromyography; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Meningitis, Fungal; Nose Diseases; Opportunistic Infections; Rare Diseases; Risk Assessment; Severity of Illness Index; Treatment Outcome; Triazoles; Zygomycosis

2013
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
    The Cochrane database of systematic reviews, 2014, Feb-24, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2014
Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand.
    Internal medicine journal, 2014, Volume: 44, Issue:12b

    Topics: Antifungal Agents; Aspergillosis; Australia; Chemoprevention; Consensus Development Conferences as Topic; Data Collection; Diagnostic Tests, Routine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; New Zealand; Opportunistic Infections; Practice Guidelines as Topic; Pre-Exposure Prophylaxis; Triazoles

2014
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.
    Internal medicine journal, 2014, Volume: 44, Issue:12b

    Topics: Antifungal Agents; Consensus; Drug Administration Schedule; Drug Delivery Systems; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Hematologic Neoplasms; Humans; Molecular Sequence Data; Mycoses; Opportunistic Infections; Practice Guidelines as Topic; Rehydration Solutions; Triazoles; Voriconazole

2014
Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents.
    Current opinion in infectious diseases, 2016, Volume: 29, Issue:4

    Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; Humans; Mucorales; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Salvage Therapy; Transplant Recipients; Triazoles

2016
First case of Trichoderma longibrachiatum infection in a renal transplant recipient in Tunisia and review of the literature.
    La Tunisie medicale, 2010, Volume: 88, Issue:1

    Topics: Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Trichoderma; Tunisia; Voriconazole

2010
The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2010, Volume: 43, Issue:3

    Topics: Aged; Antifungal Agents; Diabetes Mellitus, Type 2; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Risk Factors; Saccharomycetales; Treatment Outcome; Triazoles; Voriconazole

2010
Rhodotorula fungemia: two cases and a brief review.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Female; Fungemia; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Pyrimidines; Rhodotorula; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries

2011
Posaconazole: a new antifungal weapon.
    Reviews on recent clinical trials, 2011, Volume: 6, Issue:3

    Topics: Antifungal Agents; Clinical Trials as Topic; Drug Interactions; Drug Resistance, Fungal; Humans; Immunocompromised Host; Kidney Diseases; Mycoses; Opportunistic Infections; Triazoles

2011
Pulmonary aspergillosis: recent advances.
    Seminars in respiratory and critical care medicine, 2011, Volume: 32, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Disease Susceptibility; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Opportunistic Infections; Pulmonary Aspergillosis; Triazoles

2011
Invasive mycoses: strategies for effective management.
    The American journal of medicine, 2012, Volume: 125, Issue:1 Suppl

    Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Antifungal Agents; Antineoplastic Agents; Aspartate Aminotransferases; Aspergillosis; Bilirubin; Biomarkers; Drug Monitoring; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Leukemia; Liver; Liver Function Tests; Male; Middle Aged; Mucormycosis; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Pneumonia; Risk Factors; Triazoles

2012
Safety and interactions of new antifungals in stem cell transplant recipients.
    Expert opinion on drug safety, 2012, Volume: 11, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Interactions; Echinocandins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Opportunistic Infections; Pharmacovigilance; Renal Insufficiency; Stem Cell Transplantation; Triazoles

2012
Immunosuppression and Chagas disease: a management challenge.
    PLoS neglected tropical diseases, 2013, Volume: 7, Issue:1

    Topics: Adult; Antiprotozoal Agents; Chagas Disease; Female; Humans; Immunocompromised Host; Male; Middle Aged; Nifurtimox; Nitroimidazoles; Opportunistic Infections; Triazoles; Trypanosoma cruzi

2013
Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.
    The Journal of infection, 2004, Volume: 48, Issue:1

    Topics: Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Humans; Immunocompromised Host; Lipopeptides; Male; Mitosporic Fungi; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole

2004
New options for the treatment of invasive fungal infections.
    Seminars in oncology, 2004, Volume: 31, Issue:2 Suppl 4

    Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2004
Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole.
    The Pediatric infectious disease journal, 2004, Volume: 23, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Endocarditis; Female; Follow-Up Studies; Fungemia; Fusarium; Humans; Immunocompromised Host; Infant; Leukemia, Myeloid, Acute; Liposomes; Opportunistic Infections; Pyrimidines; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole

2004
Aspergillus mediastinitis following orthotopic heart transplantation: case report and review of the literature.
    Transplant infectious disease : an official journal of the Transplantation Society, 2004, Volume: 6, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Administration Schedule; Heart Transplantation; Humans; Male; Mediastinitis; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2004
Voriconazole versus amphotericin B in cancer patients with neutropenia.
    The Cochrane database of systematic reviews, 2006, Jan-25, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2006
Invasive Acremonium strictum infection in a bone marrow transplant recipient.
    The Pediatric infectious disease journal, 2006, Volume: 25, Issue:3

    Topics: Acremonium; Antifungal Agents; Bone Marrow Transplantation; Child; Female; Humans; Male; Mycoses; Opportunistic Infections; Osteomyelitis; Pyrimidines; Tibia; Triazoles; Urine; Voriconazole

2006
[Zygomycosis after hematogeneic stem cell transplantation--a current problem?].
    Medizinische Klinik (Munich, Germany : 1983), 2006, Sep-15, Volume: 101, Issue:9

    Topics: Aspergillosis; Cancer Care Facilities; Cross Infection; Cross-Sectional Studies; Germany; Hematopoietic Stem Cell Transplantation; Humans; Long-Term Care; Opportunistic Infections; Pyrimidines; Risk Factors; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis

2006
[Current indications for voriconazole in onco-hematological patients].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Drug Resistance, Fungal; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Salvage Therapy; Spain; Triazoles; Voriconazole; Zygomycosis

2007
[The role of voriconazole in the treatment of emerging mycoses].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2007
Prevention of invasive fungal infections in patients with neoplastic disease.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17 Suppl 2

    Topics: Amphotericin B; Aspergillosis; Candidiasis; Cytokines; Drug Administration Routes; Humans; Imidazoles; Neoplasms; Opportunistic Infections; Polyenes; Triazoles

1993
New approaches to antifungal chemotherapy.
    Medical mycology, 1998, Volume: 36 Suppl 1

    Topics: Amphotericin B; Animals; Antifungal Agents; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Fungi; Humans; Mycoses; Opportunistic Infections; Randomized Controlled Trials as Topic; Triazoles

1998
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.
    The oncologist, 2000, Volume: 5, Issue:2

    Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neoplasms; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2000
Novel triazole antifungal agents.
    Expert opinion on investigational drugs, 2000, Volume: 9, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Humans; Immunocompromised Host; Mycoses; Opportunistic Infections; Triazoles

2000
Antimycotic agents in oral candidosis: an overview: 1. Clinical variants.
    Dental update, 2000, Volume: 27, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Cheilitis; Drug Resistance, Microbial; Glossitis; Humans; Immunocompromised Host; Opportunistic Infections; Stomatitis, Denture; Treatment Outcome; Triazoles

2000
Oral candidal infections and antimycotics.
    Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists, 2000, Volume: 11, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles

2000

Trials

7 trial(s) available for triazoles and Opportunistic Infections

ArticleYear
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial.
    Lancet (London, England), 2018, 12-01, Volume: 392, Issue:10162

    Topics: Accidental Falls; Antirheumatic Agents; Arthritis, Psoriatic; Double-Blind Method; Drug Therapy, Combination; Female; Headache; Hip Fractures; Humans; Janus Kinase 1; Janus Kinase Inhibitors; Male; Middle Aged; Nasopharyngitis; Opportunistic Infections; Pneumonia; Pyridines; Severity of Illness Index; Triazoles

2018
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.
    Lancet (London, England), 2018, 12-01, Volume: 392, Issue:10162

    Topics: Adult; Antirheumatic Agents; Double-Blind Method; Female; Humans; Janus Kinase 1; Janus Kinase Inhibitors; Male; Middle Aged; Nasopharyngitis; Opportunistic Infections; Pneumonia; Pyridines; Severity of Illness Index; Spondylitis, Ankylosing; Treatment Outcome; Triazoles

2018
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2011, Volume: 15, Issue:5

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2011
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
    The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Female; Fluconazole; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mycoses; Opportunistic Infections; Risk Factors; Triazoles

2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
    The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Fluconazole; Humans; Itraconazole; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Opportunistic Infections; Single-Blind Method; Treatment Outcome; Triazoles

2007
Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease.
    Pharmacotherapy, 2007, Volume: 27, Issue:12

    Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antifungal Agents; Body Weight; Chronic Disease; Diarrhea; Double-Blind Method; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Racial Groups; Sex Factors; Transplantation, Homologous; Triazoles

2007
Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17, Issue:6

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Female; Humans; Leukemia; Male; Middle Aged; Mycoses; Neoplasms; Opportunistic Infections; Prospective Studies; Triazoles

1993

Other Studies

98 other study(ies) available for triazoles and Opportunistic Infections

ArticleYear
Frequency of occurrence, seasonal variation and antifungal susceptibility of opportunistic Mucorales isolated from hospital soils in Iran.
    Mycoses, 2021, Volume: 64, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Cunninghamella; Hospitals; Humans; Iran; Microbial Sensitivity Tests; Mucor; Mucorales; Mucormycosis; Opportunistic Infections; Rhizopus; Seasons; Soil; Soil Microbiology; Triazoles

2021
Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019).
    The Journal of antibiotics, 2021, Volume: 74, Issue:8

    Topics: Antifungal Agents; Asia; Aspergillus; Aspergillus fumigatus; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Pacific Islands; Public Health Surveillance; Triazoles

2021
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
    Diagnostic microbiology and infectious disease, 2021, Volume: 101, Issue:3

    Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Europe; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; North America; Opportunistic Infections; Triazoles; Voriconazole

2021
Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis.
    International journal of hematology, 2018, Volume: 107, Issue:2

    Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Treatment Outcome; Triazoles; Young Adult

2018
Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients.
    Microbial pathogenesis, 2018, Volume: 115

    Topics: Adolescent; Antifungal Agents; Candida; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; Fluconazole; Humans; Kluyveromyces; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Nitriles; Opportunistic Infections; Pichia; Pyridines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole

2018
    Journal de mycologie medicale, 2018, Volume: 28, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Diabetes Complications; Diabetes Mellitus; Female; Humans; Immunocompromised Host; Male; Maxillary Sinus; Middle Aged; Mucorales; Mucormycosis; Opportunistic Infections; Sinusitis; Tooth Extraction; Treatment Outcome; Triazoles

2018
Overview and outcome of mucormycosis among children with cancer: Report from the Children's Cancer Hospital Egypt.
    Mycoses, 2019, Volume: 62, Issue:11

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Cancer Care Facilities; Child; Child, Preschool; Egypt; Female; Hematologic Neoplasms; Hospitals, Pediatric; Humans; Immunocompromised Host; Male; Mucormycosis; Neoplasms; Opportunistic Infections; Retrospective Studies; Risk Factors; Treatment Outcome; Triazoles

2019
Mucormycosis: More Than Meets the Eye!
    The American journal of medicine, 2019, Volume: 132, Issue:9

    Topics: Adult; Amphotericin B; Antifungal Agents; Cavernous Sinus Thrombosis; Debridement; Delayed Diagnosis; Diabetes Complications; Humans; Magnetic Resonance Imaging; Male; Mucormycosis; Ophthalmoplegia; Opportunistic Infections; Orbit Evisceration; Orbital Cellulitis; Sinusitis; Triazoles

2019
Disseminated mucormycosis.
    Intensive care medicine, 2019, Volume: 45, Issue:10

    Topics: Antifungal Agents; Female; Humans; Leukemia, Myeloid; Middle Aged; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory Insufficiency; Shock, Septic; Tomography, X-Ray Computed; Triazoles

2019
[Hemoptysis complicating bronchopulmonary mucormycosis in a diabetic patient].
    Revue de pneumologie clinique, 2013, Volume: 69, Issue:2

    Topics: Aged, 80 and over; Amphotericin B; Combined Modality Therapy; Diabetes Mellitus, Type 2; Hemoptysis; Humans; Lung Diseases, Fungal; Male; Mucormycosis; Opportunistic Infections; Pneumonectomy; Triazoles

2013
Dermatic Scedosporium apiospermum infection after autologous bone marrow transplantation.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:6

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Dermatomycoses; Drugs, Chinese Herbal; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Opportunistic Infections; Postoperative Complications; Pyrimidines; Scedosporium; Skin Ulcer; Transplantation Conditioning; Transplantation, Autologous; Triazoles; Voriconazole; Young Adult

2013
Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
    Journal de mycologie medicale, 2012, Volume: 22, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Fungal; Head and Neck Neoplasms; Humans; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Nystatin; Opportunistic Infections; Saccharomyces cerevisiae; Species Specificity; Terbinafine; Triazoles

2012
[Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient].
    Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:2

    Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Caspofungin; Echinocandins; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lung; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds.
    Journal of clinical microbiology, 2013, Volume: 51, Issue:8

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Nitriles; Opportunistic Infections; Pyridines; Triazoles

2013
Atypical presentation of invasive pulmonary aspergillosis in a liver transplant recipient.
    Annals of transplantation, 2013, May-23, Volume: 18

    Topics: Adolescent; Antifungal Agents; Hepatoblastoma; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Liver Neoplasms; Liver Transplantation; Male; Opportunistic Infections; Pyrimidines; Solitary Pulmonary Nodule; Time Factors; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:1

    Topics: Acremonium; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2014
Voriconazole-induced periostitis in two post-transplant patients.
    Journal of radiology case reports, 2013, Volume: 7, Issue:8

    Topics: Antifungal Agents; Female; Heart Transplantation; Humans; Male; Middle Aged; Opportunistic Infections; Periostitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Radionuclide Imaging; Radiopharmaceuticals; Stem Cell Transplantation; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Review: voriconazole for prevention or treatment of invasive fungal infections in cancer with neutropenia.
    Annals of internal medicine, 2014, Jul-15, Volume: 161, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Humans; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles

2014
[Cutaneous mucormycosis as a rare complication of a liver transplantation].
    Enfermedades infecciosas y microbiologia clinica, 2014, Volume: 32, Issue:8

    Topics: Abdominal Wall; Acute Kidney Injury; Adult; Amphotericin B; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Clostridium Infections; Cytomegalovirus Infections; Debridement; Dermatomycoses; Hepatitis; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Mucormycosis; Opportunistic Infections; Postoperative Complications; Primary Graft Dysfunction; Reoperation; Triazoles

2014
Invasive cardiac aspergillosis after orthotopic liver transplantation.
    Zeitschrift fur Gastroenterologie, 2014, Volume: 52, Issue:8

    Topics: Acute Disease; Caspofungin; Drug Therapy, Combination; Echinocandins; Echocardiography, Transesophageal; Hepatitis B; Humans; Lipopeptides; Liver Failure; Liver Transplantation; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Opportunistic Infections; Postoperative Complications; Pulmonary Aspergillosis; Triazoles

2014
Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:4

    Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antifungal Agents; Child; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Retrospective Studies; Taiwan; Treatment Outcome; Triazoles; Young Adult

2016
Invasive cardiac aspergillosis presenting as complete heart block in a patient with acute lymphoblastic leukaemia.
    European heart journal, 2015, Jun-21, Volume: 36, Issue:24

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cardiomyopathies; Electrocardiography; Heart Block; Humans; Male; Middle Aged; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Triazoles

2015
Breakthrough invasive fungal infection under the use of posaconazole and voriconazole.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2016, Volume: 115, Issue:5

    Topics: Antifungal Agents; Colletotrichum; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Opportunistic Infections; Triazoles; Voriconazole

2016
Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and prop
    Diagnostic microbiology and infectious disease, 2015, Volume: 82, Issue:4

    Topics: Antifungal Agents; Drug Resistance, Fungal; Echinocandins; Fungi; Global Health; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyridines; Triazoles

2015
Disseminated fusariosis by Fusarium proliferatum in a patient with aplastic anaemia receiving primary posaconazole prophylaxis - case report and review of the literature.
    Mycoses, 2016, Volume: 59, Issue:1

    Topics: Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus flavus; Coinfection; Fatal Outcome; Fusariosis; Fusarium; Humans; Immunocompromised Host; Male; Opportunistic Infections; Triazoles; Young Adult

2016
In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen.
    Journal de mycologie medicale, 2016, Volume: 26, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Environmental Microbiology; Humans; Iran; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Opportunistic Infections; Triazoles; Voriconazole

2016
Recurrent trichosporonosis with central nervous system involvement in an allogeneic hematopoietic stem cell transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5

    Topics: Anemia, Aplastic; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Central Nervous System; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrocephalus; Immunocompromised Host; Immunosuppression Therapy; Laminectomy; Lipopeptides; Magnetic Resonance Imaging; Opportunistic Infections; Recurrence; Transplantation, Autologous; Treatment Outcome; Triazoles; Trichosporon; Trichosporonosis; Ventriculoperitoneal Shunt; Voriconazole

2016
Successful Treatment of Rhino-Orbital-Cerebral Mucormycosis in a Child With Leukemia.
    Journal of pediatric hematology/oncology, 2017, Volume: 39, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Brain; Child, Preschool; Female; Humans; Hyperbaric Oxygenation; Mucormycosis; Naphthalenes; Nose; Opportunistic Infections; Orbit; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Terbinafine; Triazoles

2017
Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis.
    Mycopathologia, 2008, Volume: 166, Issue:2

    Topics: Administration, Oral; Antifungal Agents; Antineoplastic Agents; Fatal Outcome; Humans; Leukemia; Male; Middle Aged; Mycetoma; Opportunistic Infections; Pyrimidines; Recurrence; Scedosporium; Triazoles; Voriconazole

2008
Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Europe; Fungi; Guidelines as Topic; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Triazoles; Yeasts

2008
Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
    Revista iberoamericana de micologia, 2008, Dec-31, Volume: 25, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Brazil; Cross Infection; Dermatomycoses; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungemia; Hospitals, University; Humans; Mycological Typing Techniques; Mycoses; Onychomycosis; Opportunistic Infections; Organ Specificity; Triazoles; Trichosporon; Urine; Vaginitis

2008
In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi.
    Medical mycology, 2009, Volume: 47, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyridines; Triazoles

2009
Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:1

    Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Cross Infection; Echinocandins; Fungemia; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2009
[Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces capitatus (Geotrichum capitatum) by two different methods].
    Mikrobiyoloji bulteni, 2009, Volume: 43, Issue:2

    Topics: Antifungal Agents; Dipodascus; Fluconazole; Geotrichosis; Humans; Itraconazole; Microbial Sensitivity Tests; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2009
Concomitant Aspergillus and Cytomegalovirus infection in heart transplant: early diagnosis is the key to successful treatment.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2009, Volume: 7, Issue:3

    Topics: Acute Disease; Antifungal Agents; Antiviral Agents; Cardiomyopathy, Dilated; Cytomegalovirus Infections; Early Diagnosis; Ganciclovir; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Opportunistic Infections; Pulse Therapy, Drug; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2009
Scedosporium apiospermum: an emerging opportunistic pathogen that must be distinguished from Aspergillus and other hyalohyphomycetes.
    Journal of cutaneous pathology, 2009, Volume: 36 Suppl 1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Diagnosis, Differential; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycetoma; Opportunistic Infections; Pyrimidines; Scedosporium; Skin Diseases; Triazoles; Voriconazole

2009
Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:12

    Topics: Antifungal Agents; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fungi; Histone Deacetylase Inhibitors; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Triazoles

2009
[Non-fatal disseminated mucormycosis in a solid organ transplant].
    Revue des maladies respiratoires, 2009, Volume: 26, Issue:9

    Topics: Absidia; Adult; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Debridement; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Mucormycosis; Opportunistic Infections; Thyroid Diseases; Triazoles

2009
Subcutaneous phaeohyphomycosis in a renal transplant recipient successfully treated with voriconazole.
    Acta dermato-venereologica, 2009, Volume: 89, Issue:6

    Topics: Adult; Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2009
CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2.
    Journal of acquired immune deficiency syndromes (1999), 2010, Volume: 54, Issue:4

    Topics: CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Clinical Trials as Topic; Cyclohexanes; Drug Resistance, Viral; HIV Fusion Inhibitors; Humans; Maraviroc; Opportunistic Infections; T-Lymphocytes; Time Factors; Treatment Outcome; Triazoles

2010
Voriconazole-associated myositis.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2009, Volume: 15, Issue:7

    Topics: Acute Disease; Adult; Antifungal Agents; Aspergillosis; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Myositis; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2009
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010, Volume: 16, Issue:1

    Topics: Adult; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Cohort Studies; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Liver; Liver Function Tests; Lymphocyte Depletion; Male; Opportunistic Infections; Pyrimidines; Retrospective Studies; Risk Factors; Statistics as Topic; T-Lymphocytes; Triazoles; Voriconazole

2010
Successful triple combination therapy of disseminated absidia corymbifera infection in an adolescent with osteosarcoma.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:2

    Topics: Absidia; Adolescent; Amphotericin B; Antineoplastic Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Femoral Neoplasms; Humans; Lipopeptides; Mucormycosis; Opportunistic Infections; Osteosarcoma; Triazoles

2010
Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
    Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:1

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida tropicalis; Candidiasis; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Fungemia; Humans; Infant; Lipopeptides; Male; Micafungin; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2010
Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2010, Volume: 29, Issue:11

    Topics: Adult; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Case-Control Studies; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Multivariate Analysis; Mycoses; Opportunistic Infections; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Sunlight; Triazoles; Voriconazole

2010
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
    Bone marrow transplantation, 2011, Volume: 46, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2011
Sinonasal mucormycosis: case report.
    European annals of otorhinolaryngology, head and neck diseases, 2010, Volume: 127, Issue:1

    Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Diabetes Complications; Diabetic Ketoacidosis; Endoscopy; Ethmoid Sinusitis; Humans; Infusions, Intravenous; Male; Mucormycosis; Opportunistic Infections; Rhinitis; Tomography, X-Ray Computed; Triazoles

2010
Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:2

    Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Opportunistic Infections; Periostitis; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Radiography; Radionuclide Imaging; Triazoles; Voriconazole

2011
[Fatal outcome of invasive tracheal aspergillosis].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2011, Volume: 183, Issue:5

    Topics: Antifungal Agents; Bronchi; Carotid Artery, External; Caspofungin; Contrast Media; Echinocandins; Fatal Outcome; Hemoptysis; Humans; Image Processing, Computer-Assisted; Iohexol; Lipopeptides; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, Spiral Computed; Trachea; Tracheal Diseases; Triazoles; Voriconazole; Young Adult

2011
Disseminated nocardiosis masking an atypical zygomycosis presentation in a kidney transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Brain Abscess; Coinfection; Female; Humans; Kidney Transplantation; Middle Aged; Nocardia; Nocardia Infections; Opportunistic Infections; Pneumonia, Bacterial; Radiography; Triazoles; Zygomycosis

2011
Cutaneous fusariosis developing in a post-irradiation site.
    Dermatology online journal, 2011, May-15, Volume: 17, Issue:5

    Topics: Adult; Combined Modality Therapy; Cyclosporine; Debridement; Dermatomycoses; Female; Fusarium; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg Ulcer; Lymphoma, Non-Hodgkin; Opportunistic Infections; Postoperative Complications; Prednisone; Pyrimidines; Radiodermatitis; Radiotherapy; Skin Neoplasms; Triazoles; Voriconazole

2011
Pigmented fruiting bodies and birefringent crystals in a surgical wound: A clue to Aspergillus niger infection.
    Journal of cutaneous pathology, 2011, Volume: 38, Issue:8

    Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus niger; Crystallization; Debridement; Fruiting Bodies, Fungal; Humans; Male; Opportunistic Infections; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole

2011
A case of pseudomembranous colitis after voriconazole therapy.
    Yonsei medical journal, 2011, Volume: 52, Issue:5

    Topics: Adult; Antifungal Agents; Enterocolitis, Pseudomembranous; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2011
A common fungus, an unusual (and deadly) infection.
    The American journal of medicine, 2011, Volume: 124, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Biopsy; Debridement; Fatal Outcome; Female; Hemochromatosis; Hepatic Encephalopathy; Humans; Intubation, Gastrointestinal; Liver; Liver Failure, Acute; Middle Aged; Mucormycosis; Necrosis; Nose; Nose Diseases; Opportunistic Infections; Triazoles

2011
[Vertebral aspergillosis in a cirrhotic patient: an uncommon cause of spondylitis].
    Enfermedades infecciosas y microbiologia clinica, 2012, Volume: 30, Issue:4

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomarkers; Cross Infection; Fatal Outcome; Galactose; Haemophilus influenzae; Hepatitis C, Chronic; Humans; Immunocompromised Host; Liver Cirrhosis; Low Back Pain; Lumbar Vertebrae; Male; Mannans; Middle Aged; Multiple Organ Failure; Opportunistic Infections; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Spondylitis; Triazoles; Voriconazole

2012
Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis--case analysis to plan better targeted prophylactic or therapeutic measurement.
    Klinische Padiatrie, 2012, Volume: 224, Issue:3

    Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole

2012
Posaconazole as successful treatment for fungemia due to Cryptococcus albidus in a liver transplant recipient.
    QJM : monthly journal of the Association of Physicians, 2013, Volume: 106, Issue:4

    Topics: Antifungal Agents; Cryptococcosis; Fungemia; Humans; Liver Transplantation; Male; Middle Aged; Opportunistic Infections; Triazoles

2013
[Disseminated infection due to Geotrichum capitatum].
    Medecine et maladies infectieuses, 2012, Volume: 42, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Geotrichosis; Geotrichum; Granuloma; Hepatitis; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lipopeptides; Male; Neutropenia; Opportunistic Infections; Sepsis; Triazoles

2012
Ochroconis gallopavum infection in a lung transplant recipient: report of a case.
    Transplantation proceedings, 2012, Volume: 44, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Biopsy; Bronchiolitis Obliterans; Disease Progression; Drug Administration Schedule; Enterobacter cloacae; Enterococcus; Fatal Outcome; Humans; Imipenem; Lung Transplantation; Male; Opportunistic Infections; Phaeohyphomycosis; Pyrimidines; Respiratory Tract Infections; Skin; Sputum; Tobramycin; Treatment Outcome; Triazoles; Voriconazole

2012
Mohs micrographic surgery for the treatment of localized cutaneous alternariosis.
    Journal of the American Academy of Dermatology, 2013, Volume: 68, Issue:2

    Topics: Alternariosis; Antifungal Agents; Humans; Male; Middle Aged; Mohs Surgery; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2013
Paecilomyces variotii central nervous system infection in a patient with cancer.
    Mycoses, 2003, Volume: 46, Issue:1-2

    Topics: Antifungal Agents; Breast Neoplasms; Central Nervous System Infections; Cerebrospinal Fluid; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Paecilomyces; Triazoles

2003
Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:2

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycetoma; Naphthalenes; Opportunistic Infections; Pyrimidines; Risk Assessment; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2003
Successful treatment with voriconazole of cerebral aspergillosis in an hematologic patient.
    Haematologica, 2003, Volume: 88, Issue:3

    Topics: Antifungal Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Neuroaspergillosis; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2003
Posaconazole: SCH 56592.
    Drugs in R&D, 2003, Volume: 4, Issue:4

    Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Cytochrome P-450 Enzyme Inhibitors; Humans; Mycoses; Opportunistic Infections; Oxidoreductases; Sterol 14-Demethylase; Treatment Outcome; Triazoles

2003
Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:9

    Topics: Acute Disease; Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Female; Hepatitis; Humans; Leukemia; Lung Diseases, Fungal; Opportunistic Infections; Osteomyelitis; Pyrimidines; Remission Induction; Sacroiliac Joint; Splenic Diseases; Triazoles; Voriconazole

2003
Successful treatment of Scedosporium pneumonia with voriconazole during AML therapy and bone marrow transplantation.
    Medical and pediatric oncology, 2003, Volume: 41, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Mycetoma; Opportunistic Infections; Pyrimidines; Risk Assessment; Scedosporium; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole

2003
Successful treatment of Acremonium fungemia with voriconazole.
    Mycoses, 2003, Volume: 46, Issue:11-12

    Topics: Acremonium; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Female; Fungemia; Humans; Lymphoma, Mantle-Cell; Middle Aged; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2003
Use of voriconazole in candida retinitis.
    Eye (London, England), 2005, Volume: 19, Issue:4

    Topics: Adult; Antifungal Agents; Candidiasis; Eye Infections, Fungal; Fatal Outcome; Female; Humans; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2005
Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease.
    The Pediatric infectious disease journal, 2004, Volume: 23, Issue:6

    Topics: Adolescent; Amphotericin B; Aspergillosis; Aspergillus nidulans; Caspofungin; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Granulomatous Disease, Chronic; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Risk Assessment; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2004
Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.
    Cancer, 2004, Oct-01, Volume: 101, Issue:7

    Topics: Adult; Aged; Amphotericin B; Aspergillosis; Aspergillus; Aspergillus fumigatus; Cross Infection; Drug Resistance, Fungal; Female; Humans; Leukemia; Male; Middle Aged; Neutropenia; Opportunistic Infections; Retrospective Studies; Risk Factors; Triazoles

2004
Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6

    Topics: Adolescent; Antifungal Agents; Bradycardia; Female; Fusarium; Humans; Mycoses; Opportunistic Infections; Pyrimidines; Tachycardia, Ventricular; Torsades de Pointes; Triazoles; Voriconazole

2004
Combination antifungal therapy for invasive aspergillosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2004
Combination therapy for invasive aspergillosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6

    Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2004
Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2004, Volume: 23, Issue:12

    Topics: Antifungal Agents; Fusarium; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Opportunistic Infections; Triazoles

2004
Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.
    Annals of diagnostic pathology, 2005, Volume: 9, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bone Marrow Transplantation; Drug Resistance, Fungal; Fungemia; Gastrointestinal Diseases; Graft vs Host Disease; Granuloma; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2005
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
    British journal of haematology, 2005, Volume: 131, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Austria; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Genes, Fungal; Hematologic Neoplasms; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Peptides, Cyclic; Prevalence; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2005
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
    Recenti progressi in medicina, 2005, Volume: 96, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis.
    Ophthalmology, 2006, Volume: 113, Issue:7

    Topics: Adult; Antifungal Agents; Aspergillosis; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Immunosuppressive Agents; Injections; Lung Transplantation; Opportunistic Infections; Pyrimidines; Triazoles; Visual Acuity; Vitrectomy; Vitreous Body; Voriconazole

2006
[Clinical cases in medical mycology. Case no. 21].
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Endophthalmitis; Exophiala; Female; Fungemia; Humans; Itraconazole; Middle Aged; Mycoses; Opportunistic Infections; Osteolysis; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Th2 Cells; Triazoles; Voriconazole

2006
[Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2006, Volume: 47, Issue:8

    Topics: Antifungal Agents; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
[Successful treatment by voliconazole for pulmonary and adductor magnus muscle aspergillosis induced by immunosuppressive therapy for hypersensitivity pneumonia].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2006, Volume: 44, Issue:10

    Topics: Aged; Alveolitis, Extrinsic Allergic; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cyclosporine; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Fungal; Myositis; Opportunistic Infections; Prednisolone; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
Prophylaxis and aspergillosis--has the principle been proven?
    The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4

    Topics: Antifungal Agents; Aspergillosis; Fluconazole; Graft vs Host Disease; Humans; Itraconazole; Mycoses; Neutropenia; Opportunistic Infections; Triazoles

2007
Posaconazole prophylaxis in hematologic cancer.
    The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Opportunistic Infections; Triazoles

2007
Posaconazole prophylaxis in hematologic cancer.
    The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21

    Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Research Design; Triazoles

2007
Posaconazole prophylaxis in hematologic cancer.
    The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Humans; Mucositis; Mycoses; Opportunistic Infections; Oxidoreductases; Point Mutation; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole

2007
Invasive tracheal aspergillosis treated successfully with voriconazole: clinical report and review of the literature.
    The Annals of otology, rhinology, and laryngology, 2007, Volume: 116, Issue:10

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus flavus; Fatal Outcome; Female; Humans; Laryngoscopy; Leukemia, Myeloid, Acute; Opportunistic Infections; Pyrimidines; Tracheitis; Triazoles; Voriconazole

2007
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Antifungal Agents; Aspergillus; Candida; Fluconazole; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2008
Voriconazole plasma monitoring.
    Archives of disease in childhood, 2008, Volume: 93, Issue:7

    Topics: Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Drug Monitoring; Humans; Leukemia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2008
Non-Candida albicans Candida mediastinitis of odontogenic origin in a diabetic patient.
    Medical mycology, 2008, Volume: 46, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Diabetes Mellitus, Type 2; Female; Humans; Mediastinitis; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2008
Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2008, Volume: 51, Issue:3

    Topics: Adolescent; Aspergillosis; Aspergillus fumigatus; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Thyroid Diseases; Tomography, X-Ray Computed; Triazoles; Voriconazole

2008
Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.
    British journal of haematology, 1997, Volume: 97, Issue:3

    Topics: Acute Disease; Adolescent; Antifungal Agents; Aspergillosis; Brain Diseases; Humans; Leukemia; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

1997
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.
    Journal of clinical microbiology, 1998, Volume: 36, Issue:10

    Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Culture Media; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Structure-Activity Relationship; Triazoles; Yeasts

1998
Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole.
    Scandinavian journal of infectious diseases, 2000, Volume: 32, Issue:3

    Topics: Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Triazoles; Voriconazole

2000
Optimal use of the newer antifungal agents.
    Oncology (Williston Park, N.Y.), 2000, Volume: 14, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Drugs, Investigational; Humans; Immunocompromised Host; Mycoses; Opportunistic Infections; Randomized Controlled Trials as Topic; Triazoles

2000
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Journal of clinical microbiology, 2001, Volume: 39, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2001
[AIDS: bad prognosis in candidiasis. Cryptococcosis in brain involvement is usually fatal--experiences with a new therapeutic drug].
    Fortschritte der Medizin, 1989, Mar-15, Volume: 107, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Meningitis; Opportunistic Infections; Prognosis; Triazoles

1989
[AIDS fungus infections. Fluconazole--a new preparation in development].
    Fortschritte der Medizin, 1989, Mar-30, Volume: 107, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Opportunistic Infections; Triazoles

1989
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Brain Diseases; Cryptococcosis; Female; Fluconazole; Ketoconazole; Lung Diseases, Fungal; Mice; Opportunistic Infections; Triazoles

1987